A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer
|
|
文献详情
编号/登记号：
注册时间：
研究开始时间：
研究结束时间：
项目类型：
本院角色：
多中心研究：
招募状态：
试验分期：
研究疾病/适应症：
研究类型：
研究单位：[1]Jiangsu HengRui Medicine Co., Ltd.[2]UMHAT 'Deva Maria'. EOOD Burgas, Bulgaria[3]MHAT - Dobrich. AD Dobrich, Bulgaria[4]MHAT 'Dr. Tota Venkova'. AD Gabrovo, Bulgaria[5]Complex Oncological Center - Plovdiv. EOOD Plovdiv, Bulgaria[6]MHAT 'Central Onco Hospital'. OOD Plovdiv, Bulgaria[7]Acibadem City Clinic Tokuda Hospital Ead Sofia, Bulgaria[8]Affiliated Hospital of Hebei University Baoding, China[9]Beijing Cancer Hospital Beijing, China[10]Beijing Friendship Hospital, Capital Medical University Beijing, China[11]Peking Union Medical College Hospital Beijing, China[12]The third hospital of Peking University Beijing, China[13]Tumor Hospital of the Chinese Academy of Medical Sciences Beijing, China[14]China Japan Friendship Hospital of Jilin University Changchun, China[15]The first hospital of Jilin University Changchun, China[16]Hunan Cancer Hospital Changsha, China[17]West China Hospital of Sichuan University Chengdu, China[18]Army characteristic medical center of the Chinese people's Liberation Army Chongqing, China[19]Chongqing Cancer Hospital Chongqing, China[20]The First Affiliated Hospital of Army Medical University Chongqing, China[21]The First Affiliated Hospital of Fujian Medical University Fuzhou, China[22]Sun Yat-Sen hospital of Sun Yat-Sen University Guangzhou, China[23]Sun Yat-sen University Cancer Center Guangzhou, China[24]The First Affiliated Hospital of Zhejiang University Medicine college Hangzhou, China[25]The Second affiliated hospital of zhejiang university medical college Hangzhou, China[26]Zhejiang Cancer Hospital Hangzhou, China[27]Zhejiang Province People's Hospital Hangzhou, China[28]Anhui Provincial Hospital Hefei, China[29]The First Affiliated Hospital of Anhui Medical University Hefei, China[30]Qilu Hospital of Shandong University Jinan, China[31]Yunnan Provincial Cancer Hospital Kunming, China[32]The second hospital of Lanzhou University Lanzhou, China[33]The First Affiliated Hospital of Nanchang University Nanchang, China[34]Gulou Hospital Affiliated to Medical College of Nanjing University Nanjing, China[35]Jiangsu Provincial Cancer Hospital Nanjing, China[36]Jiangsu Provincial People's Hospital Nanjing, China[37]Huadong Hospital of Fudan University Shanghai, China[38]Ruijin Hospital Shanghai, China[39]Shanghai General Hospital Shanghai, China[40]The Cancer Hospital of Fudan University Shanghai, China[41]Zhongshan Hospital of Fudan University Shanghai, China[42]Liaoning Provincial Cancer Hospital Shenyang, China[43]The fourth hospital of Hebei Medical University Shijia Zhuang, China河北医科大学第四医院[44]The second hospital of Tianjin Medical University Tianjing, China[45]The First Affiliated Hospital of Wenzhou Medical University Wenzhou, China[46]Hubei Provincial Cancer Hospital Wuhan, China[47]Tongji Hospital, Tongji medical college of HUST Wuhan, China[48]Union Hospital, Tongji Medical college of HUST Wuhan, China[49]Wuxi People's Hospital Wuxi, China[50]The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, China[51]The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China[52]The First Affiliated Hospital of Xiamen University Xiamen, China[53]Jiangsu Subei people's Hospital Yangzhou, China[54]Henan people's Hospital Zhengzhou, China[55]Henan Provincial Cancer Hospital Zhengzhou, China[56]The First Affiliated Hospital of Zhengzhou University Zhengzhou, China[57]RESEARCH SITE s.r.o. Plzen, Plzeň, Czechia[58]Fakultni nemocnice u sv. Anny v Brne Brno, Czechia[59]Fakultni nemocnice Olomouc Pavlov, Czechia[60]Nemocnice Na Homolce Praha, Czechia[61]Krajska zdravotni a.s. - Masarykova nemocnice v Usti nad Labem o.z. Ústí Nad Labem, Czechia[62]Beskidzkie Centrum Onkologii im.Jana Pawla II Bielsko-Biala, Bielsko-Biała, Poland[63]LexMedica Osrodek Badan Klinicznych Wesoła, Weigla, Poland[64]KO-MED Centra Kliniczne Biala Podlaska Biała Podlaska, Poland[65]Swietokrzyskie Centrum Onkologii Kielce, Poland[66]Provita Profamilia Piotrków Trybunalski, Poland[67]Wojewodzki Szpital Specjalistyczny im. J. Korczaka Słupsk, Poland[68]Complex oncological center - Bourgas Burgas, Bulgaria
The aim of this study is to compare the safety and efficacy of SHR3680 with bicalutamide in the treatment of patients with hormone sensitive prostate cancer.
